Covered recipient · General Payments record
RANDALL COLVIN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,613.46
- Reported across 113 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,188.74 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MeMed US, Inc. | $716.62 | 1 |
| Abbott Laboratories | $146.64 | 7 |
| ABBVIE INC. | $119.21 | 7 |
| Novo Nordisk AS | $108.22 | 5 |
| GlaxoSmithKline, LLC. | $29.40 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $25.11 | 1 |
| Astellas Pharma US Inc | $15.14 | 1 |
| Phathom Pharmaceuticals, Inc. | $15.07 | 1 |
| PFIZER INC. | $13.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.07 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124855237 | CMS |
| Abbott Laboratories | $22.12 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124855239 | CMS |
| Abbott Laboratories | $22.24 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124855241 | CMS |
| Abbott Laboratories | $17.21 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124855245 | CMS |
| Abbott Laboratories | $19.73 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124855243 | CMS |
| Abbott Laboratories | $21.43 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124855247 | CMS |
| Abbott Laboratories | $22.84 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124855249 | CMS |
| ABBVIE INC. | $23.17 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494103 | CMS |
| ABBVIE INC. | $13.52 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494105 | CMS |
| ABBVIE INC. | $13.91 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494107 | CMS |
| ABBVIE INC. | $14.57 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494109 | CMS |
| ABBVIE INC. | $15.24 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494111 | CMS |
| ABBVIE INC. | $15.14 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494113 | CMS |
| ABBVIE INC. | $23.66 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103494115 | CMS |
| Astellas Pharma US Inc | $15.14 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139367389 | CMS |
| Boston Scientific Corporation | $25.11 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092398646 | CMS |
| GlaxoSmithKline, LLC. | $29.40 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116532500 | CMS |
| MeMed US, Inc. | $716.62 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154905511 | CMS |
| Novo Nordisk Inc | $19.02 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097190486 | CMS |
| Novo Nordisk Inc | $14.38 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096875973 | CMS |
| Novo Nordisk Inc | $22.35 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096748835 | CMS |
| Novo Nordisk Inc | $22.75 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097741717 | CMS |
| Novo Nordisk Inc | $29.72 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096920906 | CMS |
| PFIZER INC. | $13.33 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131199448 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.07 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151051299 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.